No shortage on file

ENALAPRILAT INJECTION USP

HIKMA CANADA LIMITED

Quick answers

Is there a shortage of ENALAPRILAT INJECTION USP in Canada?

No. There is no current shortage of ENALAPRILAT INJECTION USP 1.25MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file1 product

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

VASOTEC IV

SANDOZ CANADA INCORPORATED

1.25MG · DIN 01923846

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

DIN

02388499

Strength

1.25MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

ENALAPRILAT

See all ENALAPRILAT products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-09-25

Resolved

Disruption of the manufacture of the drug.

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.4MG · DIN 02432188

ATROPINE INJECTION BP

0.6MG · DIN 02432196

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

2MG · DIN 02457075